Biocompatible viscoelastic gel slurries, their preparation and use
First Claim
1. A method of controlling the rheological and diffusion properties of a biocompatible viscoelastic gel slurry comprising a two phase mixture, a first phase being a particulate biocompatible gel phase, said gel phase comprising a chemically cross-linked glycosaminoglycan, or said glycosaminoglycan chemically co-cross-linked with at least one other polymer selected from the group consisting of polysaccharides and proteins, said gel phase being swollen in a physiologically acceptable aqueous medium and being uniformly distributed in the second phase, said second phase comprising a polymer solution of a water-soluble biocompatible polymer selected from the group consisting of polysaccharides, polyvinylpyrrolidone and polyethylenloxide in said physiologically acceptable aqueous medium, said method comprising changing the polymer concentration in the gel phase by partial removal of the physiologically acceptable aqueous medium from the equilibrated swollen gel before combining said two phases;
- said partial removal being effected by subjecting the gel phase to compression, such that there results a 1.05 to 1000 fold increase in the polymer concentration in the gel phase.
2 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are biocompatible viscoelastic gel slurries formed from a polymeric gel, preferably a hyaluronan or a derivative thereof such as hylan swollen in an aqueous medium and a fluid phase which is an aqueous solution of a polymer which may also but not necessarily be a hyaluronan or derivative thereof. Also disclosed are methods of making such slurries, controlling their rheological properties and the uses thereof.
-
Citations
3 Claims
-
1. A method of controlling the rheological and diffusion properties of a biocompatible viscoelastic gel slurry comprising a two phase mixture, a first phase being a particulate biocompatible gel phase, said gel phase comprising a chemically cross-linked glycosaminoglycan, or said glycosaminoglycan chemically co-cross-linked with at least one other polymer selected from the group consisting of polysaccharides and proteins, said gel phase being swollen in a physiologically acceptable aqueous medium and being uniformly distributed in the second phase, said second phase comprising a polymer solution of a water-soluble biocompatible polymer selected from the group consisting of polysaccharides, polyvinylpyrrolidone and polyethylenloxide in said physiologically acceptable aqueous medium, said method comprising changing the polymer concentration in the gel phase by partial removal of the physiologically acceptable aqueous medium from the equilibrated swollen gel before combining said two phases;
- said partial removal being effected by subjecting the gel phase to compression, such that there results a 1.05 to 1000 fold increase in the polymer concentration in the gel phase.
- View Dependent Claims (2, 3)
Specification